TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: 3-month complete response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Center of pressure sway area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Variation of anti-SARS-CoV-2 antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Barthel Index for Activities of Daily Living
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of clusters
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Quality of clusters
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change from Baseline in Ocular Surface Disease Index (OSDI) Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from Baseline in Current Symptom Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of CMV disease/replication
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Vastus Medialis Activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Differences in lesion detection at different imaging time points
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of Postoperative functional outcome - ROM with goniometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change of Postoperative functional outcome - pain
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Change of Postoperative functional outcome - Western Ontario and McMaster Universities Arthritis Index (WOMAC)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change of Postoperative functional outcome - FJS
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change of Postoperative functional outcome - Knee Society Score (KSS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Proportion of patients with serious infections
Endpoint domain: Adverse events/effects
Primary endpoint: Ulcer healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Mean percentage change in LDL-C
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of ETT exchange
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mandibular anterior segment alignment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in PTSD Knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Self-Reported Arousal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glittre Activities Of Daily Living Test
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Incidence of complications of cirrhosis and infections
Endpoint domain: Adverse events/effects
Primary endpoint: Blood VA/sTREM2 level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prosocial behaviors
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Efficiency of local anesthesia injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Protein profile changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Metabolite profile changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Characterization of fecal microbiome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Tmax (Time of maximum observed concentration)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax (Maximum observed concentration)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-inf (Area under the concentration-time curve extrapolated to infinity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in cardiac function in DMD patient
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: change in thyroid function in DMD patient
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: change in cognitive function in DMD patients
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Speech Intelligibility in noise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Femoral head perfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Pittsburgh Sleep Quality Index (PSQI) total scores
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Continuous positive airway pressure adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5-year tooth survival
Endpoint domain: Mortality/survival
Primary endpoint: Rate of neurodevelopmental impairment or Death
Endpoint domain: Mortality/survival
Primary endpoint: Cranial vertebral angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Agreement between impedancemetry measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Magnitude of change in perceived joint position
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Progression-free survival 2 (PFS2)
Endpoint domain: Mortality/survival
Primary endpoint: Accuracy of prehospital diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration-time Curve From Time of Administration to the Last Measurable Concentration (AUClast)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration-time Curve From Time of Administration to Time of Infinity (AUCinf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline of Schirmer's Test Value at Day 31
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline of Tear Film Breakup Time at Day 31
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline of Ocular Surface Index at Day 31
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Uterotonic usage habits
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patients' knowledge of lung cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction with Communication
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Confidence in Decision
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Basal Activation in Trapezius and Serratus muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Electromyographic mDurance® after exercises
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Aesthetic Outcomes
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Incidence of nasal bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Prediction of liver fibrosis in MAFLD progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brain injury markers (tau, GFAP, NSE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Non-motor responses during tactile stimulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in youth substance use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in youth sexual risk-taking
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Deliveries below 34 weeks of gestation
Endpoint domain: Mortality/survival
Primary endpoint: Number of participants with 'Moderate' or 'Severe' symptoms of cybersickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intensive care unit hospitalization rate
Endpoint domain: Mortality/survival
Primary endpoint: proportion of discharged patients
Endpoint domain: Mortality/survival
Primary endpoint: National Early Warning Score (NEWS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with adequate colon cleansing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Emergence of sensory self-awareness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in acrophobia symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percent adoption of OmniSeq NGS testing platform
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Subjective Ratings of Acute Thermal Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical activity level (objective)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in neurocognitive performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in social-cognitive performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in community functioning performance
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Drinking before sex (frequency)
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Drinking before sex (quantity)
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Condomless sex
Endpoint domain: Adverse events/effects
Primary endpoint: Observed Child Social Communication
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Observed Child Disruptive Behavior
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Family Life Impairment Scale
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Number of participants with major response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in LPP Amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in basal energy expenditure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Participant-reported Efficiency When Preparing for Patient Consultations
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Participant-reported Efficacy of Using Navify Oncology Hub
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: total consumption of opioid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in PHQ-9 Scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in GAD-7 Scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Eurohis-QOL-8 Scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in CSS 15+ Scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of all planned daily video supported ward rounds provided
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of all planned self-measurements transmitted by patient
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of all acute contact requests from patients handled within pre-defined time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Hemoglobin measure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: AUCt of CKD-391(2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of CKD-391(2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in mandibular flexure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Whole brain volumes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Focal demyelinating lesion volumes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent completion
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Adherence to treatment protocol
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Nasolabial esthetics
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: correlation of genetic mutation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: correlation of genetic mutation burden and prognosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence and severity of treatment emergent adverse events (TEAEs) and serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with Clinically significant abnormality findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence and severity of injection site reactions (ISRs)
Endpoint domain: Adverse events/effects
Primary endpoint: Mean change in Time in Range (TIR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: post-surgical hematoma formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: mHealth App Usability Score (Patient)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: mHealth App Usability Score (Healthcare Professional)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Modified Borg Dyspnea (RPE) scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Dyspnea Index Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Esophageal and tracheal temperature measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidents of treatment-emergent serious adverse events (TESAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: ≥75% improvement in Eczema Area and Severity Index score (EASI75)
Endpoint domain: Adverse events/effects
Primary endpoint: Objective response after 8 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fMRI Signals
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Quality of Recovery (QoR-15) questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Food Waste Weight
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Image quality evaluation of CTPA images
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 3D lower limb kinematics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 3D lower limb kinetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients receiving prehospital transfusion with full study data
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of patients completing transfusion of at least 1 unit of assigned blood products prior to arrival
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of patients completing transfusion of all assigned blood products at the receiving hospital
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Feasibility Assessed by Enrollment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: rate of identification and exposure of the external laryngeal nerve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Proportion of admitted injured patients receiving each element of the ACTFAST Program
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of admitted injured patients receiving elements of the ACTFAST Program
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Patient firearm safety attitudes and behaviors as assessed by survey
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Immuno-oxidative abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Occurrence of hypothermia
Endpoint domain: Adverse events/effects
Primary endpoint: Effect on body weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of Anti-Idursulfase Antibodies Formation
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With at Least One Solicited Local Adverse Event (AE) Within 8 Days After the Injection of Prime Dose
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With at Least One Solicited Systemic AE Within 8 Days After the Injection of Prime Dose
Endpoint domain: Adverse events/effects
Primary endpoint: Change From Baseline in Hemoglobin at Day 8 in Participants Without Booster Dose (Cohorts 1 and 2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Percentage of subjects with ≥ 1.0 log10 IU/mL decline of HBsAg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Safety and tolerability of SPX-101
Endpoint domain: Adverse events/effects
Primary endpoint: measurement of the candidate biomarker
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dynamics of 18F-fluciclovine uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes of arterial PaO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Changes of PaO2/FiO2 ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Primary safety endpoints
Endpoint domain: Adverse events/effects
Primary endpoint: Safety of Vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Feasibility of Vaccination
Endpoint domain: Resource use
Primary endpoint: Effect of Vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Obstetric Quality of Recovery
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Renal diseases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Liver steatosis and fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Low bone mineral density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Percentage of Participants Achieving Responder Status for Global Aesthetic Improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Complete Ulcer Healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: sFLT1 concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in De Jong Gierveld Scale
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Changes in Patient-Reported Outcomes Measurement Information Systems - Social Isolation
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Forearm hydration degree assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Effects of Skin Disease on Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Breathing registration during sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Accuracy of behavioral performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total immunoglobulin (IgG) concentration of CSL760
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Maximum concentration (Cmax) of CSL760
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration-time curve (AUC) from time 0 to the last measurable concentration (AUC0-last) of CSL760
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Related Grade 2 or Higher Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in allelic frequencies related to thrombosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Increase in thrombophilia cases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Proportion of HCV RNA positive who initiate HCV treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cross-sectional area of the multifidus muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Number of patients with complete overall, pulmonary, structural, and biochemical response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients who survive without progression of disease after 5 years following protocol treatment
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of all patients enrolled who show increased radioactive iodine avidity at 6 months following selpercatinib monotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The incidence of adverse events and dose limiting toxicity with the combination of selpercatinib and 131I therapy
Endpoint domain: Adverse events/effects